Investors & Media

Financials

HomeInvestors & MediaFinancials

Status of ABL Bio’s funds

ABL Bio’s surplus funds are held in bank deposit, etc..
In accordance with K-IFRS(Korean International Financial Reporting Standards), they are presented in financial statement as cash and cash equivalents, financial assets at fair value through profit or loss, etc..

The status of ABL Bio’s funds in the last three years is as follows.

(Unit: million KRW)

Status of ABL Bio’s funds list
FY2020 FY2021 2022.Q3
Current Assets
Cash and cash equivalents 40,658 21,589 21,917
Financial assets at fair value through profit or loss 29,733 22,058 40,355
Non-Current Assets
Financial assets at fair value through profit or loss 20,620 13,503 59,929
Total amount of Funds Held 91,011 57,150 122,201

Statement of Financial Position

(Unit : million KRW)

FY 2017, FY 2018, 2019.Q3 list
FY 2020 FY 2021 2022.Q3(Consolidated)
Current Assets 71,920 45,473 95,533
Non-Current Assets 27,975 19,980 67,759
Total Assets 99,895 65,453 163,292
Current Liabilities 7,969 8,751 76,246
Non-Current Liabilities 1,261 749 2,288
Total Liabilities 9,230 9,500 78,534
[Controlling interests] 90,665 55,953 84,758
Capital Stock 23,123 23,562 23,829
Other Capital 366,601 374,926 382,452
Accumulated other comprehensive income - - -14
Retained Earnings -299,059 -342,535 -321,509
[Non-controlling interests] - - -
Total Equity 90,665 55,953 84,758
Total Equity & Liabilities 99,895 65,453 163,292

Income Statement

(Unit : million KRW)

FY 2017, FY 2018, 2019.Q3 list
FY 2020 FY 2021 2022.Q3(Consolidated)
Operating Revenue 8,104 5,332 57,397
Operating Expenses 67,751 57,637 45,205
Operating Profit -59,647 -52,305 12,192
Financial Income 9,671 8,644 11,016
Financial Expenses 4,354 1,056 2,240
Other Income 36 1,171 76
Other Expenses 1,312 12 17
Income before income taxes -55,606 -43,558 21,026
Net Profit(Loss) -55,606 -43,558 21,026
Other comprehensive income -168 82 -14
Total comprehensive income -55,774 -43,476 21,012
Earnings per share (Unit: KRW) -1,207 -927 443